70,000 Shares in Ambrx Biopharma Inc. Bought by Monashee Investment Management LLC
About 67% of Ambrx Biopharma's investor base is looking to short. The analysis of current outlook of investing in Ambrx Biopharma American suggests that many traders are alarmed regarding Ambrx Biopharma's prospects. Ambrx Biopharma's investing sentiment overview a quick insight into current market opportunities from investing in Ambrx Biopharma American. Many technical investors use Ambrx Biopharma American stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Ambrx |
Monashee Investment Management LLC bought a new position in shares of Ambrx Biopharma Inc. in the 3rd quarter, according to the company in its most recent disclosure with the Securities Exchange Commission. The firm bought 70,000 shares of the companys stock, valued at approximately 805,000. Monashee Investment Management LLC owned
Read at thelincolnianonline.com
 |
Ambrx Biopharma Fundamental Analysis
We analyze Ambrx Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ambrx Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ambrx Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Ambrx Biopharma is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Ambrx Biopharma American Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ambrx Biopharma stock to make a market-neutral strategy. Peer analysis of Ambrx Biopharma could also be used in its relative valuation, which is a method of valuing Ambrx Biopharma by comparing valuation metrics with similar companies.
Peers
Ambrx Biopharma Related Equities
| ENVB | Enveric Biosciences | 32.08 | ||||
| ZURA | Zura Bio | 13.33 | ||||
| IMMX | Immix Biopharma | 12.66 | ||||
| XFOR | X4 Pharmaceuticals | 8.11 | ||||
| ABOS | Acumen Pharmaceuticals | 1.59 | ||||
| SONN | Sonnet Biotherapeutics | 0.65 | ||||
| CNSP | Cns Pharmaceuticals | 0.41 | ||||
| INZY | Inozyme Pharma | 0.83 | ||||
| DAWN | Day One | 4.03 | ||||
| ELEV | Elevation Oncology | 5.45 | ||||
| HEPA | Hepion Pharmaceuticals | 7.14 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Ambrx Stock
If you are still planning to invest in Ambrx Biopharma American check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Ambrx Biopharma's history and understand the potential risks before investing.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |